Michelle Boisen
NPI 1700028818 · Gynecologic Oncology Physician · Pittsburgh, PA
Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Michelle Boisen is a Gynecologic Oncology Physician provider in Pittsburgh, PA (NPI 1700028818).
Provider details
- NPI number
- 1700028818
- Entity type
- Individual
- Primary specialty
- Gynecologic Oncology PhysicianAllopathic & Osteopathic Physicians
- Sex
- Female
- Sole proprietor
- No
- License
- 443396 (PA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
17 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
140 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Subsequent Hospital Care With Straightforward Or Low Level of Medical Decision Making, Per Day, If Using Time, at Least 25 Minutes99231 | 38 | $47 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 27 | $92 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 21 | $63 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 21 | $121 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 18 | $137 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'S |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) |
|---|---|
| Letrozole | 21 |
| Apixabanbrand: Eliquis | 19 |
| Prochlorperazine Maleate | 18 |
| Anastrozole | 18 |
| Dexamethasone | 13 |
| Levonorgestrel/Ethin.estradiolbrand: Levonorgestrel-Eth Estradiol | 12 |
| Prednisone | 12 |
| Clobetasol Propionate | 11 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$158 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2009-04-03
- Last updated
- 2021-03-25
Frequently asked questions
- What is Michelle Boisen's NPI number?
- Michelle Boisen's National Provider Identifier (NPI) is 1700028818, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Michelle Boisen's specialty?
- Michelle Boisen is listed in the NPPES registry with a primary specialty of Gynecologic Oncology Physician (Allopathic & Osteopathic Physicians).
- Where is Michelle Boisen located?
- Michelle Boisen's practice location on file with NPPES is 300 Halket St, Pittsburgh, PA 15213-3108.
- What is Michelle Boisen's phone number?
- The practice phone number listed in the NPPES registry for Michelle Boisen is (412) 641-6412.
- Does Michelle Boisen accept Medicare?
- Michelle Boisen is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Michelle Boisen's NPI active?
- Yes — Michelle Boisen's NPI (1700028818) is active in the NPPES registry as of the last update on 2021-03-25.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.